| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6444708 | UPJOHN | Treatment using venlafaxine |
Jun, 2013
(10 years ago) | |
| US6310101 | UPJOHN | Treatments using venlafaxine |
Jun, 2013
(10 years ago) | |
| US5916923 | UPJOHN | Venlafaxine for the treatment of generalized anxiety disorder |
Jun, 2013
(10 years ago) | |
|
US5916923 (Pediatric) | UPJOHN | Venlafaxine for the treatment of generalized anxiety disorder |
Dec, 2013
(10 years ago) | |
|
US6444708 (Pediatric) | UPJOHN | Treatment using venlafaxine |
Dec, 2013
(10 years ago) | |
| US6403120 | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Mar, 2017
(7 years ago) | |
| US6419958 | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Mar, 2017
(7 years ago) | |
| US6274171 | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Mar, 2017
(7 years ago) | |
|
US6274171 (Pediatric) | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Sep, 2017
(6 years ago) | |
|
US6419958 (Pediatric) | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Sep, 2017
(6 years ago) | |
|
US6403120 (Pediatric) | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Sep, 2017
(6 years ago) | |
Effexor Xr is owned by Upjohn.
Effexor Xr contains Venlafaxine Hydrochloride.
Effexor Xr has a total of 11 drug patents out of which 11 drug patents have expired.
Expired drug patents of Effexor Xr are:
- US6444708
- US6310101
- US5916923
- US5916923*PED
- US6444708*PED
- US6403120
- US6419958
- US6274171
- US6274171*PED
- US6419958*PED
- US6403120*PED
Effexor Xr was authorised for market use on 20 October, 1997.
Effexor Xr is available in capsule, extended release;oral dosage forms.
Effexor Xr can be used as treatment of depression and generalized anxiety disorder, treatment of social anxiety disorder, treatment of generalized anxiety disorder, treatment of panic disorder.
The generics of Effexor Xr are possible to be released after 20 September, 2017.
Drugs and Companies using VENLAFAXINE HYDROCHLORIDE ingredient
Market Authorisation Date: 20 October, 1997
Treatment: Treatment of generalized anxiety disorder; Treatment of panic disorder; Treatment of depression and generalized anxiety disorder; Treatment of social anxiety disorder
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
EFFEXOR XR family patents
